Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjorie R Jenkins

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
BMJ Simulation & Technology Enhanced Learning|May 6, 2022
Evaluation of Technical Competency in Healthcare Simulation (E-TeCHS) tool: a modified Delphi studyPatrick G Hughes, Steven Scott Atkinson, Mira F Brown, et al.
International Reviews of Immunology|May 12, 2011
Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapiesMaurizio Chiriva-Internati, Leonardo Mirandola, W Martin Kast, et al.
Cleveland Clinic Journal of Medicine|August 13, 2008
Putting the latest data into practice: case studies and clinical considerations in menopausal managementMargaret McKenzie, Andrea L Sikon, Holly L Thacker, et al.
Plos One|July 19, 2011
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myelomaLeonardo Mirandola, Yuefei Yu, Kitty Chui, et al.
BMC Cancer|September 20, 2011
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4Leonardo Mirandola, Yuefei Yu, Marjorie R Jenkins, et al.
Biology of Sex Differences|October 28, 2016
Sex and gender in medical education: a national student surveyMarjorie R Jenkins, Alyssa Herrmann, Amanda Tashjian, et al.
Journal of Applied Toxicology : JAT|December 1, 2010
Nanotechnology and human health: risks and benefitsAnna Giulia Cattaneo, Rosalba Gornati, Enrico Sabbioni, et al.
International Reviews of Immunology|May 12, 2011
Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancerLeonardo Mirandola, Martin J Cannon, Everardo Cobos, et al.
Plos One|May 21, 2010
Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancerMaurizio Chiriva-Internati, Yuefei Yu, Leonardo Mirandola, et al.
Pharmaceutical Statistics|August 16, 2021
Heterogeneity in treatment effects across diverse populationsBridget M Nugent, Rajanikanth Madabushi, Barbara Buch, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
BMJ Simulation & Technology Enhanced Learning|May 6, 2022
Evaluation of Technical Competency in Healthcare Simulation (E-TeCHS) tool: a modified Delphi studyPatrick G Hughes, Steven Scott Atkinson, Mira F Brown, et al.
International Reviews of Immunology|May 12, 2011
Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapiesMaurizio Chiriva-Internati, Leonardo Mirandola, W Martin Kast, et al.
Cleveland Clinic Journal of Medicine|August 13, 2008
Putting the latest data into practice: case studies and clinical considerations in menopausal managementMargaret McKenzie, Andrea L Sikon, Holly L Thacker, et al.
Plos One|July 19, 2011
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myelomaLeonardo Mirandola, Yuefei Yu, Kitty Chui, et al.
BMC Cancer|September 20, 2011
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4Leonardo Mirandola, Yuefei Yu, Marjorie R Jenkins, et al.
Biology of Sex Differences|October 28, 2016
Sex and gender in medical education: a national student surveyMarjorie R Jenkins, Alyssa Herrmann, Amanda Tashjian, et al.
Journal of Applied Toxicology : JAT|December 1, 2010
Nanotechnology and human health: risks and benefitsAnna Giulia Cattaneo, Rosalba Gornati, Enrico Sabbioni, et al.
International Reviews of Immunology|May 12, 2011
Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancerLeonardo Mirandola, Martin J Cannon, Everardo Cobos, et al.
Plos One|May 21, 2010
Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancerMaurizio Chiriva-Internati, Yuefei Yu, Leonardo Mirandola, et al.
Pharmaceutical Statistics|August 16, 2021
Heterogeneity in treatment effects across diverse populationsBridget M Nugent, Rajanikanth Madabushi, Barbara Buch, et al.
Pageof 4